Evaxion Biotech logo
Evaxion Biotech
EVAX | NASDAQ
Chart Builder DCF Calculator
$2.77
+$0.03 (+0.96%)
At close: Nov 16, 2026, 4:00 PM ET
$2.77
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

Evaxion Biotech Company Profile

Company profile explained

Company Profile

Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacterial and viral pathogens. Founded in 2008, Evaxion Biotech A/S is headquartered in Hørsholm, Denmark.

Key Executives

Name Position
Helen Katrina Tayton-Martin Chief Executive Officer
Thomas Frederik Schmidt Chief Financial Officer
Andreas Holm Mattsson Founder & Chief AI Officer
Benjamin Ole Wolthers Vice President of Clinical Development
Birgitte Rono Chief Scientific Officer & COO

Latest SEC Filings

Date Type Title
Oct 30, 2026 6-K Filing
Oct 23, 2026 6-K Filing
Oct 19, 2026 6-K Filing
Oct 02, 2026 6-K Filing
Sep 14, 2026 6-K Filing
Sep 04, 2026 6-K Filing
Aug 20, 2026 6-K Filing
Aug 20, 2026 6-K Filing
Aug 17, 2026 6-K Filing
Aug 14, 2026 6-K Filing
View All SEC Filings ➞
Evaxion Biotech
Evaxion Biotech logo
Country Denmark
IPO Date Feb 5, 2021
Industry Biotechnology
Sector Healthcare
Employees 46
CEO Helen Katrina Tayton-Martin

Contact Details

Dr. Neergaards Vej Horsholm, North Dakota 2970 Denmark

Stock Details

Ticker Symbol EVAX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001828253
CUSIP Number 29970R303
ISIN Number US29970R3030
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.